Elisavet Paplomata, MD
- Assistant Professor of Hematology & Medical Oncology, Emory University School of Medicine
Sponsored Research Projects
- A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2 Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
- CBKM120F2303 - A phase III randomized, double blind, placebo controlled study of
Program Topics
Affiliated Units
- Emory University School of Medicine